1. Home
  2. MOLN vs CLAR Comparison

MOLN vs CLAR Comparison

Compare MOLN & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • CLAR
  • Stock Information
  • Founded
  • MOLN 2004
  • CLAR 1957
  • Country
  • MOLN Switzerland
  • CLAR United States
  • Employees
  • MOLN N/A
  • CLAR N/A
  • Industry
  • MOLN
  • CLAR Recreational Games/Products/Toys
  • Sector
  • MOLN
  • CLAR Consumer Discretionary
  • Exchange
  • MOLN Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • MOLN 142.6M
  • CLAR 139.4M
  • IPO Year
  • MOLN 2021
  • CLAR N/A
  • Fundamental
  • Price
  • MOLN $3.72
  • CLAR $3.82
  • Analyst Decision
  • MOLN Hold
  • CLAR Strong Buy
  • Analyst Count
  • MOLN 1
  • CLAR 3
  • Target Price
  • MOLN $4.00
  • CLAR $5.33
  • AVG Volume (30 Days)
  • MOLN 5.2K
  • CLAR 93.0K
  • Earning Date
  • MOLN 11-05-2025
  • CLAR 11-06-2025
  • Dividend Yield
  • MOLN N/A
  • CLAR 2.62%
  • EPS Growth
  • MOLN N/A
  • CLAR N/A
  • EPS
  • MOLN N/A
  • CLAR N/A
  • Revenue
  • MOLN $856,302.00
  • CLAR $254,200,000.00
  • Revenue This Year
  • MOLN N/A
  • CLAR N/A
  • Revenue Next Year
  • MOLN $1,000.00
  • CLAR $4.38
  • P/E Ratio
  • MOLN N/A
  • CLAR N/A
  • Revenue Growth
  • MOLN N/A
  • CLAR N/A
  • 52 Week Low
  • MOLN $3.36
  • CLAR $3.02
  • 52 Week High
  • MOLN $7.60
  • CLAR $5.29
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 50.93
  • CLAR 56.67
  • Support Level
  • MOLN $3.69
  • CLAR $3.45
  • Resistance Level
  • MOLN $3.85
  • CLAR $4.03
  • Average True Range (ATR)
  • MOLN 0.21
  • CLAR 0.14
  • MACD
  • MOLN 0.01
  • CLAR 0.03
  • Stochastic Oscillator
  • MOLN 14.29
  • CLAR 63.79

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: